Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies.
Medicaid insurance status appears to be independently associated with deficits in overall survival.
»
04/04/16
ADAM17 is a tumor promoter and therapeutic target in Western diet-associated colon cancer.
ADAM17 is a WD-inducible enzyme activated by CXCL12-CXCR4 signaling.
»
07/25/16
Altered tryptophan metabolism in human meningioma.
TRP metabolism favors towards kynurenine pathway in human meningioma.
»
03/02/16
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival.
Young age seems to be particularly prognostic in women with luminal breast cancers.
»
08/03/16
Does the vaginal microbiota plays a role in the development of cervical cancer?
There appears to be a temporal relationship between the VM and HPV.
»
04/13/16
Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer.
cfDNA level was significantly associated with TNM stage, lymph node involvement and jaundice.
»
01/26/16
Familial Associations Between Prostate Cancer and Other Cancers.
Breast, kidney, and nervous system tumors and myeloma occur more often than by chance.
»
06/03/16
O(6)-Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?
Temozolomide can be considered a 'personalized' treatment if the predictive role of MGMT is further confirmed.
»
03/16/16
Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells.
Hypermethylation of the promoter region was found to be responsible for the loss of miR-200c in GC cells.
»
02/17/16
Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
Relationship between elevation of MHC class II expression and cellular apoptosis seen.
»
12/29/15
< Prev
Next >